copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases
Amicus Therapeutics - Wikipedia Amicus Therapeutics, Inc is a public American biopharmaceutical company based in Philadelphia, PA [3] The company went public in 2007 under the NASDAQ trading symbol FOLD [4]
Amicus Therapeutics (FOLD): A High-Conviction Play in Rare Disease . . . Amicus Therapeutics is a rare combination of operational excellence, strategic foresight, and innovation Its accelerating revenue, global expansion, and DMX-200 pipeline position it as a high-conviction play for investors seeking exposure to the rare disease boom
Amicus Therapeutics These highly valued statements outline the fundamental beliefs that are curcial to understanding the passion and commitment behind Amicus The statements below offer a set of standards that employees are proud to stand by, showcasing our bold nature and driven personalities
Amicus Therapeutics Announces FDA Approval and Launch of With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases
Amicus Therapeutics Programs Pipeline Our advanced product pipeline positions us at the forefront of developing therapies for devastating rare diseases
Community of Us Amicus Therapeutics is here to listen to and empower people living with rare diseases—patients, their families and caregivers, their communities and health-care professionals